Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Kärtner

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Neuroscience|October 23, 2023
The ego in psychedelic drug action - ego defenses, ego boundaries, and the therapeutic role of regressionTobias Buchborn, Hannes S Kettner, Laura Kärtner, et al.
Der Nervenarzt|February 1, 2022
[Are psychedelics fast acting antidepressant agents?]Gerhard Gründer, Manuela Brand, Laura Kärtner, et al.
Der Nervenarzt|January 17, 2025
[Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment]Moritz Spangemacher, Jonathan Reinwald, Hana Adolphi, et al.
The Lancet. Psychiatry|December 15, 2023
Treatment with psychedelics is psychotherapy: beyond reductionismGerhard Gründer, Manuela Brand, Lea J Mertens, et al.
JAMA Psychiatry|March 18, 2026
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical TrialLea J Mertens, Michael Koslowski, Felix Betzler, et al.
Psychotherapy and Psychosomatics|May 27, 2026
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialLea J Mertens, Felix Betzler, Manuela Brand, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Neuroscience|October 23, 2023
The ego in psychedelic drug action - ego defenses, ego boundaries, and the therapeutic role of regressionTobias Buchborn, Hannes S Kettner, Laura Kärtner, et al.
Der Nervenarzt|February 1, 2022
[Are psychedelics fast acting antidepressant agents?]Gerhard Gründer, Manuela Brand, Laura Kärtner, et al.
Der Nervenarzt|January 17, 2025
[Mechanisms of action of antidepressive pharmacotherapy: brain and mind-body and environment]Moritz Spangemacher, Jonathan Reinwald, Hana Adolphi, et al.
The Lancet. Psychiatry|December 15, 2023
Treatment with psychedelics is psychotherapy: beyond reductionismGerhard Gründer, Manuela Brand, Lea J Mertens, et al.
JAMA Psychiatry|March 18, 2026
Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical TrialLea J Mertens, Michael Koslowski, Felix Betzler, et al.
Psychotherapy and Psychosomatics|May 27, 2026
Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b TrialLea J Mertens, Felix Betzler, Manuela Brand, et al.
Pageof 1